<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03499288</url>
  </required_header>
  <id_info>
    <org_study_id>MPR15FA89628</org_study_id>
    <nct_id>NCT03499288</nct_id>
  </id_info>
  <brief_title>Profiling Children and Youth With Cerebral Palsy in Relation to Feeding and Nutrition</brief_title>
  <acronym>Purple-N</acronym>
  <official_title>A Multi-country, Multi-centre, Observational, Cross-sectional Study to Evaluate Individualized Treatment and Management in Children and Adolescents With Cerebral Palsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nutricia Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nutricia Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      HCPs will complete questionnaires about their patients with Cerebral Palsy (CP) and invite
      parents/caregivers of these patients to fill in questionnaires as well. Questionnaires
      include questions on individualized treatment, nutritional profile and management, and
      patient characteristics.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Coordinating health care professionals (HCPs; e.g. paediatric neurologists, physiotherapists)
      in different centres across different countries will be asked to participate in this
      cross-sectional study.

      A) for the HCP to fill out a questionnaire about their CP child, related to general subject
      characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding
      mode and nutritional status; and B) for parents (/legal representatives) to receive and fill
      out questionnaires about their CP child and themselves, related to general subject
      characteristics, motor function, co-morbidities, type of therapies, anthropometry, feeding
      mode and nutritional status, participation and (their own) quality of life.

      If parents (/legal representatives) agree to &quot;A)&quot;, but not &quot;B)&quot; then a subject will still
      enter the study, but without the parental assessment.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 11, 2017</start_date>
  <completion_date type="Actual">July 3, 2018</completion_date>
  <primary_completion_date type="Actual">July 3, 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Quantify current CP characteristics 1 (general subject characteristics):</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
- General subject characteristics (e.g. Sex, Birth weight [g], Type of CP motor disorder [category]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 2 (anthropometry):</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Anthropometry: length [cm]; weight [grams] and BMI (kg/m2)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 3 (motor function)</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Motor function (GMFCS [category]; GMFM measurement type [GMFM-86/GMFM-88]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 4 (comorbidities)</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Comorbidities: epilepsy, cognitive function, GI problems [categories]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 5 (therapies)</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Type and frequency of physical/occupational therapy [type, number of hours per day /days per week]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 6 (feeding mode)</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Feeding mode and/or problems (tube feeding [yes/no], type of tube feeding etc)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quantify current CP characteristics 7 (nutritional status)</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Using questionnaires to quantify current CP characteristics with respect to:
Nutritional status (HCP and parent perspective on nutritional status, concerns [yes/no])</description>
  </primary_outcome>
  <other_outcome>
    <measure>Quality of life and participation 1</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Questionnaire to assess Quality of Life of subjects with CP [scores on domains]</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life and participation 2</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Questionnaire to assess Quality of Life of parents (/legal representatives) of subjects with CP [scores on domains]</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life and participation 3</measure>
    <time_frame>Data collected retrospectively, from within 12 months of entering the questionnaire</time_frame>
    <description>Level of participation included in the general parent questionnaire [categories]</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">499</enrollment>
  <condition>Cerebral Palsy</condition>
  <arm_group>
    <arm_group_label>Children and youth with cerebral palsy</arm_group_label>
    <description>Subjects between 1 month and 18 years of age with Cerebral Palsy who visited the coordinating HCP within the past 12 months.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects between 1 month and 18 years of age with Cerebral Palsy
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Confirmed diagnosis of Cerebral Palsy

          2. Age&lt;18 years

          3. Have visited the HCP within the last year

          4. Written informed consent provided by parents/legal representatives according to local
             law

        Exclusion Criteria:

          1. Neurodegenerative diseases

          2. Acute infections: meningitis, encephalitis or poliomyelitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Fakultn√≠ nemocnice v Motole</name>
      <address>
        <city>Praha</city>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Attikon University General Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bethesda Children Hospital Budapest</name>
      <address>
        <city>Budapest</city>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AO Sant'Orsola - Malpighi, Policlinico</name>
      <address>
        <city>Bologna</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST degli Spedali Civili di Brescia</name>
      <address>
        <city>Brescia</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Istituto Neurologico &quot;Carlo Besta&quot;</name>
      <address>
        <city>Milano</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>AOU di Modena - Policlinico</name>
      <address>
        <city>Modena</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Roessingh centrum voor Revalidatie</name>
      <address>
        <city>Enschede</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical university hospital of Gdansk</name>
      <address>
        <city>Gda≈Ñsk</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Szpital Kliniczny im. Heliodora ≈öwiƒôcickiego Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu</name>
      <address>
        <city>Pozna≈Ñ</city>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultn√° nemocnica Trnava</name>
      <address>
        <city>Trnava</city>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ankara University School of Medicine/Neurology</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gazi University School of Medicine/Neurology</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hacettepe University School of Medicine/Neurology</name>
      <address>
        <city>Ankara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ege University School of Medicine/Neurology</name>
      <address>
        <city>Ege</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Eskisehir Osmangazi University School of Medicine/Neurology</name>
      <address>
        <city>Eski≈üehir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inonu University School of Medicine/Neurology</name>
      <address>
        <city>ƒ∞n√∂n√º</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dokuz Eylul University School of Medicine/Neurology</name>
      <address>
        <city>ƒ∞zmir</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Marmara University School of Medicine/Neurology</name>
      <address>
        <city>Marmara</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mersin University School of Medicine/Neurology</name>
      <address>
        <city>Mersin</city>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czechia</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Slovakia</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>March 21, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 17, 2018</study_first_posted>
  <last_update_submitted>November 15, 2018</last_update_submitted>
  <last_update_submitted_qc>November 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">November 16, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebral Palsy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Paralysis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

